|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 75 of 350 found articles
| Title: |
P-003: A first-in-human phase 1 study of oral LOXO-338, a selective BCL2 inhibitor, in patients with advanced hematologic malignancies (trial in progress) |
| Author: |
Kumar, Shaji Kapoor, Prashant Alencar, Alvaro Murthy, Guru Subramanian Guru Hoffmann, Marc Pagel, John Patel, Vishalkumar Pauff, James Zinzani, Pier Luigi Gouill, Steven Le Mato, Anthony R. Jurczak, Wojciech Roeker, Lindsey E. |
| Appeared in: |
Clinical lymphoma myeloma and leukemia |
| Paging: | Volume 22 () nr. S pages S37-S38 |
| Year: |
2022 |
| Contents: | |
| Publisher: |
Elsevier Inc. |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 75 of 350 found articles
| << previous | next >> |